Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies

Xenofon Baraliakos, Filip Van den Bosch, Pedro M. Machado, Lianne S. Gensler, Helena Marzo-Ortega, Bintu Sherif, Erhard Quebe-Fehling, Brian Porter, Corine Gaillez, Atul Deodhar

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies'. Together they form a unique fingerprint.

Medicine & Life Sciences